JP2025515358A5 - - Google Patents

Info

Publication number
JP2025515358A5
JP2025515358A5 JP2024563636A JP2024563636A JP2025515358A5 JP 2025515358 A5 JP2025515358 A5 JP 2025515358A5 JP 2024563636 A JP2024563636 A JP 2024563636A JP 2024563636 A JP2024563636 A JP 2024563636A JP 2025515358 A5 JP2025515358 A5 JP 2025515358A5
Authority
JP
Japan
Prior art keywords
nutritionally
pharmaceutically
solvate
acceptable salt
therapeutically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024563636A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025515358A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2023/060827 external-priority patent/WO2023208944A1/en
Publication of JP2025515358A publication Critical patent/JP2025515358A/ja
Publication of JP2025515358A5 publication Critical patent/JP2025515358A5/ja
Pending legal-status Critical Current

Links

JP2024563636A 2022-04-25 2023-04-25 アミノ酸の組合せを有する医薬組成物および栄養補助組成物ならびに組織への脂質蓄積を特徴とする疾患におけるその使用 Pending JP2025515358A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP22382390 2022-04-25
EP22382390.7 2022-04-25
PCT/EP2023/060827 WO2023208944A1 (en) 2022-04-25 2023-04-25 Pharmaceutical and nutraceutical compositions with a combination of amino acids and its use in diseases characterized by lipid accumulation in tissues

Publications (2)

Publication Number Publication Date
JP2025515358A JP2025515358A (ja) 2025-05-14
JP2025515358A5 true JP2025515358A5 (cg-RX-API-DMAC7.html) 2026-05-08

Family

ID=81579974

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024563636A Pending JP2025515358A (ja) 2022-04-25 2023-04-25 アミノ酸の組合せを有する医薬組成物および栄養補助組成物ならびに組織への脂質蓄積を特徴とする疾患におけるその使用

Country Status (7)

Country Link
US (1) US20250268855A1 (cg-RX-API-DMAC7.html)
EP (1) EP4514147A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025515358A (cg-RX-API-DMAC7.html)
CN (1) CN119343061A (cg-RX-API-DMAC7.html)
CA (1) CA3249636A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024013203A (cg-RX-API-DMAC7.html)
WO (1) WO2023208944A1 (cg-RX-API-DMAC7.html)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JOP20190146A1 (ar) * 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
US11246846B2 (en) * 2017-10-23 2022-02-15 Michael S. Tempesta Trisodium citrate compositions having enhanced uptake across digestive mucosa

Similar Documents

Publication Publication Date Title
US5866537A (en) Pharmaceutical and/or dietetic compositions with antioxidant activity containing carnosine or derivatives and branched amino acids
CN110087647B (zh) 氨基酸组合物及肝疾病的治疗方法
JP5672264B2 (ja) 抗ヒトTNF−α抗体活性低下抑制剤
JP2020504108A5 (cg-RX-API-DMAC7.html)
ES2759584T3 (es) Prevención y tratamiento de afecciones inflamatorias
Wang et al. Anti-inflammatory activity of di-peptides derived from ovotransferrin by simulated peptide-cut in TNF-α-induced Caco-2 cells
CN104434894A (zh) 使用l-鸟氨酸苯乙酸盐治疗门静脉高压和恢复肝功能
TW200539860A (en) HMB compositions and uses thereof
CA2631647A1 (en) Use of branched-chain amino acids for the treatment of muscle loss
US20110077198A1 (en) Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition
US7094797B2 (en) Organ fibrosis inhibitor
US20170290788A1 (en) Pharmaceutical for oral delivery comprising mgbg and methods of treating disease
JP2021529736A (ja) 炎症の軽減又は治療のための組成物及び方法
CN112689508A (zh) 减少或治疗胰岛素抗性和代谢病状的组合物和方法
JP2021517578A (ja) カルシウム欠乏に起因する状態の治療に使用するための組成物
CN102458417B (zh) 核酸类似物的活性增强剂
JP2025519127A5 (cg-RX-API-DMAC7.html)
JP2021527669A5 (cg-RX-API-DMAC7.html)
JP6119969B2 (ja) 血圧降下用アミノ酸含有組成物
US20210127647A1 (en) Non-Human Animal Model of Non-Alcoholic Fatty Liver Disease
CN101014334B (zh) 丙型肝炎病毒阳性人肝硬化患者用肝癌发生和发展抑制剂
CN1287855C (zh) B型慢性肝炎治疗剂
JP2021066662A (ja) 肝脂肪低減剤
CN101060854A (zh) 具有抗糖尿病作用的蛋白质水解物
JP5100033B2 (ja) 消化管及び腎臓の萎縮抑制剤